On July 25th, Dai Aiguo, President of Hunan University of Traditional Chinese Medicine, and his delegation visited the company's Liuyang production base for research and guidance. The research team conducted on-site investigations of the company's new line extraction workshop, formulation workshop, quality testing center, and drug research institute, and visited the company's new exhibition hall.

Conduct on-site research on the extraction workshop of the new line

Visit the company exhibition hall

After the field survey, the research team held a symposium with the company's leaders in the conference room, and Shen Fanshun, the company's general manager, reported in detail to the research team on the company's profile, business performance, future development planning and other matters.

On behalf of the company, Cai Xinya warmly welcomes President Dai and his delegation to visit the company for research and guidance, and sincerely thanks the university for its kind care and strong support to the company. He stated that since the signing of a strategic cooperation agreement between Xingxiang Group and universities at the end of 2019, the company and universities have achieved a series of achievements in the promotion and application of traditional Chinese medicine ultrafine decoction pieces and traditional Chinese medicine formula granules, research on classic formulas, and industrial achievement transformation. In order to seize the historical opportunity of Hunan's strategy of creating a "strong province of traditional Chinese medicine" and a national demonstration zone for comprehensive reform of traditional Chinese medicine, the company needs to further clarify the positioning of school run enterprises in the future. We sincerely request universities to establish postdoctoral workstations and school enterprise cooperation talent training bases; Translation of scientific research achievements in traditional Chinese medicine; Development and distribution services of hospital preparations; Support will be given to the development of authentic medicinal resources in Hunan.

The leaders of relevant departments at Hunan University of Traditional Chinese Medicine have provided valuable opinions on the future development of the company, expressing strong support for the "industry university research application" in talent cultivation, standard research, new drug development, and big health product development.

President Dai Aiguo affirmed the achievements of the company in recent years, especially the newly established intelligent production line for traditional Chinese medicine formula granules. He mentioned that as a leading enterprise representing the innovative development level of traditional Chinese medicine in Hunan Province, the company has a good foundation in technology, research and development, products, sales, and other aspects. The launch of the new production line is a specific measure for the company to implement the strategic cooperation agreement signed between the university and Xingxiang Group in 2019. As one of the most successful examples of the transformation of scientific research achievements in universities, the future cooperation between the company and universities has great prospects and potential. Firstly, the company needs to strengthen cooperation with the School of Pharmacy of universities, further promote the construction of key laboratories and science and technology innovation centers for ultrafine decoction pieces, and continuously produce results in standard research, new drug development, and research and development of medicinal and edible products; Secondly, guided by market demand, focusing on the extension of the industrial chain, and combining with the technological strengths of universities, we will select products and projects that meet the company's production capacity advantages for cooperation. At the same time, the company should actively participate in projects in the university's traditional Chinese medicine technology industrial park; The third is to create synergy between science and education, and establish a good cooperative relationship between the two sides in projects such as talent cultivation through school enterprise cooperation, employment bases, and postdoctoral workstations for traditional Chinese medicine; The fourth is to further promote the cooperation between industry, academia, research and application, strengthen the cooperation in hospital preparations and classic Chinese medicine prescriptions of affiliated hospitals, and achieve the transformation of achievements and mutual benefit.

Yin Jie, Deputy Director of the Party and Government Office of Hunan University of Traditional Chinese Medicine, Wang Wei, Vice Dean of the School of Pharmacy, Liao Juan, Head of the Development Planning Department of the Development Planning and Hospital Management Office, and Qi Xinyu, Head of the Achievement and Platform Management Department of the Science and Technology Office, accompanied the research. Cai Xinya, member of the Party Committee, Vice General Manager, and Chairman of Xingxiang Group, as well as Shen Fanshun, General Manager, Tang Zhengping, Liu Yan, Kang Yongfeng, and relevant department heads, participated in the research.